We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+2.95%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13.7B
AUM Growth
+$950M
(+7.4%)
Cap. Flow
+$723M
Cap. Flow
% of AUM
5.27%
Top 10 Holdings %
Top 10 Hldgs %
11.77%
Holding
2,830
New
300
Increased
700
Reduced
765
Closed
275
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corning
GLW
|
+$45.6M |
| 2 |
Accenture
ACN
|
+$41.1M |
| 3 |
OA
Orbital ATK, Inc.
OA
|
+$33.7M |
| 4 |
Hormel Foods
HRL
|
+$32.9M |
| 5 |
PACCAR
PCAR
|
+$32.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$61.7M |
| 2 |
RFMD
RF MICRO DEVICES INC
RFMD
|
+$23.5M |
| 3 |
ORB
ORBITAL SCIENCES CORP
ORB
|
+$21.2M |
| 4 |
TAL
TAL INTERNATIONAL GROUP, INC.
TAL
|
+$21.1M |
| 5 |
Hope Bancorp
HOPE
|
+$19.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.82% |
| 2 | Healthcare | 14.78% |
| 3 | Industrials | 11.92% |
| 4 | Financials | 9.77% |
| 5 | Consumer Discretionary | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
JPMorgan Chase
JPM
$939B
| $77.8M | 0.57% |
1,283,576
-113,818
| -8% | -$6.74M |
|
27
United Parcel Service
UPS
$97.6B
| $72.9M | 0.53% |
752,021
-39,200
| -5% | -$4.02M |
|
28
Merck
MRK
$324B
| $72.6M | 0.53% |
1,323,447
+62,947
| +5% | +$3.56M |
|
29
Skyworks Solutions
SWKS
$9.06B
| $72.5M | 0.53% |
737,377
-23,801
| -3% | -$2.03M |
|
30
Cognizant
CTSH
$21.5B
| $72.1M | 0.53% |
1,156,374
+139,757
| +14% | +$8.24M |
|
31
Abbott
ABT
$180B
| $72.1M | 0.53% |
1,555,538
-60,787
| -4% | -$2.79M |
|
32
Parker-Hannifin
PH
$125B
| $69.6M | 0.51% |
585,552
+153,050
| +35% | +$18.6M |
|
33
RTX Corp
RTX
$287B
| $66.8M | 0.49% |
905,608
-129,926
| -13% | -$9.7M |
|
34
Eli Lilly
LLY
$1.07T
| $64.2M | 0.47% |
883,906
-36,291
| -4% | -$2.58M |
|
|
35
Corning
GLW
$126B
| $63.9M | 0.47% |
2,816,477
+1,917,871
| +213% | +$45.6M |
|
36
AbbVie
ABBV
$458B
| $63.4M | 0.46% |
1,083,189
-98,786
| -8% | -$5.97M |
|
37
Verizon
VZ
$194B
| $62.5M | 0.46% |
1,284,641
+233,984
| +22% | +$11.3M |
|
38
AT&T
T
$165B
| $62.1M | 0.45% |
2,519,501
+120,433
| +5% | +$3.06M |
|
39
Vanguard Dividend Appreciation ETF
VIG
$111B
| $61.7M | 0.45% |
766,448
-6,872
| -0.9% | -$557K |
|
40
Colgate-Palmolive
CL
$72.6B
| $58.3M | 0.43% |
841,451
-17,876
| -2% | -$1.24M |
|
41
US Bancorp
USB
$99.6B
| $58M | 0.42% |
1,328,607
+61,861
| +5% | +$2.71M |
|
42
Union Pacific
UNP
$183B
| $57.7M | 0.42% |
532,981
+160,900
| +43% | +$18.9M |
|
43
Gilead Sciences
GILD
$161B
| $57.5M | 0.42% |
585,796
+122,410
| +26% | +$12.4M |
|
44
Comcast
CMCSA
$79.1B
| $57.4M | 0.42% |
2,033,410
+600,042
| +42% | +$17.3M |
|
45
Labcorp
LH
$24.3B
| $57M | 0.42% |
526,312
-40,266
| -7% | -$4.14M |
|
46
Walt Disney
DIS
$165B
| $56.3M | 0.41% |
537,022
+59,114
| +12% | +$5.96M |
|
47
American Express
AXP
$223B
| $56.3M | 0.41% |
720,823
-9,034
| -1% | -$751K |
|
48
Southwest Airlines
LUV
$22.1B
| $56.2M | 0.41% |
1,269,330
+310,638
| +32% | +$13.6M |
|
49
Macy's
M
$6.15B
| $55.1M | 0.4% |
849,370
+183,048
| +27% | +$11.8M |
|
50
Omnicom Group
OMC
$22.7B
| $54.1M | 0.39% |
694,060
+45,322
| +7% | +$3.46M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2015 Portfolio in Review
As of Q1 2015, Glenmede Trust held 2,830 positions worth $13.7B, up 7.4% from $12.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Glenmede Trust deployed $723M of net new capital in Q1 2015, opening 300 new positions and adding to 700 existing holdings. Its largest new stake was Qorvo: 411,283 shares worth $32.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was NOV, an estimated $18.7M trimmed.
- Glenmede Trust's largest Q1 2015 buy was Qorvo: 411,283 shares worth $32.8M.
- Glenmede Trust added most to Corning in Q1 2015, an estimated $45.6M increase.
- Glenmede Trust's biggest Q1 2015 reduction was NOV, cutting an estimated $18.7M.
- Glenmede Trust fully exited Allergan Inc in Q1 2015, selling an estimated $61.7M.
- Glenmede Trust's ten largest holdings make up 12% of its $13.7B portfolio in Q1 2015.
- Glenmede Trust opened 300 new positions and closed 275 in Q1 2015.
- Glenmede Trust's portfolio value rose 7.4% quarter-over-quarter to $13.7B.
Based on Glenmede Trust's 13F filing for Q1 2015, filed 29 Apr 2015.